CD3G and breast cancer: More recently, two analyses of RNAseq of TI Treg cells reported the use of the ratios CCR8/FOXP3 for breast cancer and CCR8/CD3G for lung and colorectal cancers, which had a modest predictive value in terms of overall survival12,13.